HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanni Amoroso Selected Research

Stents

1/2021Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry.
12/2019Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions.
12/2018Prehospital Prasugrel Versus Ticagrelor in Real-World Patients With ST-Elevation Myocardial Infarction Referred for Primary PCI: Procedural and 30-Day Outcomes.
4/2018A clinical risk score to identify patients at high risk of very late stent thrombosis.
1/2018First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial.
8/2017Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
8/2017One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
6/2016REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
2/2016STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial.
10/2015A prospective, postmarket study with the Mguard Prime Embolic Protection Stent in ST-segment elevation myocardial infarction: the International MGuard Prime Observational Study (IMOS Prime).
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanni Amoroso Research Topics

Disease

18ST Elevation Myocardial Infarction
01/2022 - 09/2010
16Myocardial Infarction
05/2022 - 02/2004
14Thrombosis (Thrombus)
05/2022 - 07/2011
8Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2015
4Death (Near-Death Experience)
08/2017 - 09/2014
3Hemorrhage
01/2022 - 02/2004
3Pathologic Constriction (Stenosis)
01/2022 - 10/2017
2Heart Failure
05/2022 - 01/2021
2Non-ST Elevated Myocardial Infarction
11/2021 - 10/2016
2COVID-19
06/2021 - 11/2020
2Chest Pain (Chest Pains)
02/2021 - 10/2010
2Infarction (Infarctions)
01/2021 - 01/2019
2Hypertension (High Blood Pressure)
11/2020 - 06/2011
2Acute Coronary Syndrome
10/2016 - 01/2004
2Hyperplasia
11/2011 - 03/2005
2No-Reflow Phenomenon
08/2011 - 11/2005
1Infections
06/2021
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
02/2021
1Hypoxia (Hypoxemia)
02/2021
1Pathologic Dilatation (Ectasia)
04/2018
1Stroke (Strokes)
08/2011
1Atherosclerotic Plaque (Atheroma)
01/2007
1Ventricular Remodeling
11/2005
1Ischemia
07/2003
1Coronary Disease (Coronary Heart Disease)
07/2003

Drug/Important Bio-Agent (IBA)

8omega-Chloroacetophenone (Mace)IBA
01/2021 - 07/2015
6Pharmaceutical PreparationsIBA
01/2022 - 11/2005
5Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 11/2011
3Glycoproteins (Glycoprotein)IBA
05/2022 - 01/2004
2Nitrous Oxide (Laughing Gas)IBA
05/2022 - 02/2021
2TicagrelorIBA
01/2021 - 12/2018
2MetalsIBA
08/2014 - 11/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2007 - 03/2005
2Abciximab (ReoPro)FDA Link
11/2005 - 02/2004
1A 19IBA
11/2020
1Prasugrel HydrochlorideFDA Link
12/2018
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2018
1Sirolimus (Rapamycin)FDA Link
02/2016
1zotarolimusIBA
02/2016
1Phenobarbital (Luminal)FDA Link
11/2011
1nitinolIBA
08/2011
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
11/2005
1Adenosine (Adenocard)FDA LinkGeneric
11/2005
1LipidsIBA
03/2005
1Simvastatin (Zocor)FDA LinkGeneric
03/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2004
1Acetylcholine (Acetylcholine Chloride)FDA Link
07/2003

Therapy/Procedure

24Percutaneous Coronary Intervention
05/2022 - 07/2003
18Stents
01/2021 - 01/2004
6Therapeutics
05/2022 - 01/2007
5Drug-Eluting Stents
01/2022 - 11/2011
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 06/2011
2Catheters
07/2011 - 01/2004
1Defibrillators (Defibrillator)
05/2022
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
03/2018
1Aftercare (After-Treatment)
08/2017
1Thrombectomy
07/2011
1Thrombolytic Therapy
02/2004